Hirata Tetsuya, Osuga Yutaka, Hamasaki Kahori, Yoshino Osamu, Ito Mika, Hasegawa Akiko, Takemura Yuri, Hirota Yasushi, Nose Emi, Morimoto Chieko, Harada Miyuki, Koga Kaori, Tajima Toshiki, Saito Shigeru, Yano Tetsu, Taketani Yuji
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Endocrinology. 2008 Mar;149(3):1260-7. doi: 10.1210/en.2007-0749. Epub 2007 Dec 13.
IL-17A is secreted from Th17 cells, a discovery leading to revision of the mechanism underlying the role of Th1/Th2 in the immune response. Strong evidence suggests that immune responses associated with inflammation are involved in the pathogenesis of endometriosis. In the present study, we first demonstrated that the presence of Th17 cells in peritoneal fluid of endometriotic women by flow cytometric analysis and IL-17A-positive cells in endometriotic tissues by immunohistochemistry. To investigate the role of IL-17A in the development of endometriosis, we then studied the effect of IL-17A on IL-8 production, cyclooxygensase-2 expression, and cell proliferation of cultured endometriotic stromal cells (ESCs). IL-17A enhanced IL-8 secretion from ESCs in a dose-dependent manner. The IL-17A-induced secretion of IL-8 from ESCs was suppressed by anti-IL-17 receptor A antibodies or inhibitors of p38 MAPK, p42/44 MAPK, and stress-activated protein kinase/c-Jun N-terminal kinase. Addition of TNFalpha synergistically increased IL-17A-induced IL-8 secretion from ESCs. IL-17A also enhanced the expression of cyclooxygensase-2 mRNA and proliferation of ESCs. IL-17A may play a role in the development of endometriosis by stimulating inflammatory responses and proliferation of ESCs.
白细胞介素-17A(IL-17A)由辅助性T细胞17(Th17细胞)分泌,这一发现导致了对Th1/Th2在免疫反应中作用机制的修正。有力证据表明,与炎症相关的免疫反应参与了子宫内膜异位症的发病机制。在本研究中,我们首先通过流式细胞术分析证明了子宫内膜异位症患者腹腔液中存在Th17细胞,并通过免疫组织化学方法证明了子宫内膜异位症组织中存在IL-17A阳性细胞。为了研究IL-17A在子宫内膜异位症发生发展中的作用,我们随后研究了IL-17A对培养的子宫内膜间质细胞(ESC)白细胞介素-8(IL-8)产生、环氧化酶-2表达和细胞增殖的影响。IL-17A以剂量依赖的方式增强了ESC中IL-8的分泌。抗IL-17受体A抗体或p38丝裂原活化蛋白激酶(MAPK)、p42/44 MAPK和应激激活蛋白激酶/c-Jun氨基末端激酶的抑制剂可抑制IL-17A诱导的ESC中IL-8的分泌。添加肿瘤坏死因子α(TNFα)可协同增加IL-17A诱导的ESC中IL-8的分泌。IL-17A还增强了环氧化酶-2 mRNA的表达和ESC的增殖。IL-17A可能通过刺激炎症反应和ESC增殖在子宫内膜异位症的发生发展中发挥作用。